The pro-cognitive profile of the phosphodiesterase 2A inhibitor BCR909 highlights its utility as a novel treatment for diseases with cognitive decline
EUROPEAN NEUROPSYCHOPHARMACOLOGY（2011）
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined